06 October, 2026 | Tuesday | Opinion

Universities and public research institutes across the region are advancing research in cancer treatment, cell therapy, biologics and other emerging fields. The scientific foundation is growing stronger, and th...

21 September, 2026 | Monday | News

OGT, a leading global provider of genomic research and diagnostic solutions, announced the expansion of its SureSeq™ Universal NGS Unique Dual Index (UDI) range, enabling laboratories to multiplex up to 3...

02 October, 2026 | Friday | Analysis

Approvals get counted, deals get ranked, listings get priced. The other half of the year, the programmes that stopped, the applications that came back, the partnerships that ended quietly in a footnote, rarely ...

05 October, 2026 | Monday | News

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturing expertise. Integrated approach brings manufactur...

06 October, 2026 | Tuesday | News

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets), a non-covalent B...

02 October, 2026 | Friday | News

Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable AsiaMedic to reduce scan times and widen the range of complex examinations availabl...

30 September, 2026 | Wednesday | News

 Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company")...